Paul Treacy, SVP, Technical Operations at Jazz Pharmaceuticals plc (JAZZ), sold 1,402 shares at $139.62 ($196K) on 2018-03-02, disclosed to the SEC on 2018-03-05.
Seasonal sale ($196k) by SVP, Technical Operations — this insider has traded JAZZ in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $139.62 | 525 | $73K | 37.4% |
| 2 | $139.62 | 525 | $73K | 37.4% |
| 3 | $139.63 | 352 | $49K | 25.1% |
| Total | $139.62 avg | 1,402 | $196K | 100% |
| Filing → |
| JAZZ | SELL | 2019-03-04 | $195K | — | Filing → |
| JAZZ | SELL | 2018-08-13 | $462K | — | Filing → |
| JAZZ | SELL | 2018-03-07 | $168K | — | Filing → |